Characteristics | Unrealistic patients, N = 56 | Realistic patients, N = 359 | p |
---|---|---|---|
Socio-demographic | |||
Female sex1 | 55 (98.2) | 332 (92.5) | 0.152 |
Years of age | 58.5 (46.4–63) | 54.7 (44.8–60.7) | 0.082 |
Years of formal education | 9 (6–14.8) | 9 (6–13) | 0.372 |
Medium-low SE level1 | 53 (94.6) | 335 (93.3) | 1 |
RA-related | |||
Serum positive RF1 | 48 (85.7) | 325 (90.5) | 0.337 |
Serum positive ACCP1 | 49 (87.5) | 324 (90.3) | 0.481 |
Years of disease duration | 14 (8.3–20.3) | 13.2 (7.7–18.3) | 0.224 |
Rheumatoid nodes1 | 28 (50) | 67 (18.7) | ≤ 0.0001 |
RAPID-3 | 10.8 (2–18) | 4.2 (1.6–10) | 0.004 |
High disease activity category1 | 25 (44.6) | 71 (19.8) | ≤ 0.0001 |
Patient-reported outcomes | |||
Pain-VAS | 9.8 (5–31) | 5 (2–16) | ≤ 0.0001 |
Overall disease-VAS | 10 (5–35) | 5 (1–18) | 0.001 |
HAQ score | 1 (0–2.1) | 0.25 (0–1.1) | 0.001 |
SF-36 score | 61.3 (41.1–81.1) | 73 (54.3–87) | 0.002 |
Mental component score (SF-36) | 62.5 (42.9–86.9) | 76.6 (56.9–88.4) | 0.008 |
Physical component score (SF-36) | 55.3 (38–80) | 70.4 (51.4–87.8) | 0.003 |
Comorbidity | |||
Presence of comorbidity1 | 38 (67.9) | 217 (60.4) | 0.306 |
Surgical joint replacement1 | 22 (39.3) | 65 (18.1) | 0.001 |
Treatment | |||
DMARDs/patient | 1 (1–2) | 1 (1–2) | 0.031 |
Corticosteroids use1 | 29 (51.8) | 153 (42.6) | 0.247 |
Intensive treatment1 | 28 (50) | 144 (40.1) | 0.190 |
Compliance with treatment | |||
Adherence1 | 29 (51.8) | 199 (55.4) | 0.666 |
Persistence1 | 30 (53.6) | 197 (54.9) | 0.886 |
Concordance1 | 25 (44.6) | 158 (44) | 1 |
Miscellaneous | |||
Health Literacy1 | 46 (82.1) | 283 (78.8) | 0.723 |
Adequate RA knowledge1 (based on CQ) | 25 (44.6) | 170 (47.4) | 0.774 |
RA family history1 | 28 (50) | 158 (44) | 0.470 |
Significant RP1 | 32 (57.1) | 62 (17.3) | ≤ 0.0001 |
Unfavorable medical criteria | 6 (5–7) | 5 (4–6) | ≤ 0.0001 |